SAN DIEGO, Oct. 13, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that the United States District Court for the District of Delaware issued a ruling in favor of ...
SAN DIEGO, June 3, 2011 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application ...
Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), today announced that it has implemented a corporate realignment of the Company's workforce, resulting in a reduction in staff of approximately 40%, or 23 ...
LA JOLLA, Calif., Dec. 19, 2014 /PRNewswire/ -- Orexigen Therapeutics (NASDAQ: OREX) announced today that the Committee for Medicinal Products For Human Use (CHMP) of the European Medicines Agency ...
Shares of OXM rose more than 11% in the extended session Thursday after it delivered strong quarterly financial results, with profit numbers that exceeded both the company's guidance and analysts' ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
SAN DIEGO, EMBARGOED UNTIL 7:30am EDT, October 23, 2007 -- Orexigen™ Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders ...
* 48-56 percent of patients lose at least 5 pct of weight * FDA filing planned for first half of 2010 * Stock jumps 24.6 percent (Adds analyst comment, background; updates stock price) By Deena ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results